COVID-19
Measure immune system status, COVID-19 viral load, disease severity and coinfections, all in one test
Multiple Sclerosis
Monitor and personalize multiple sclerosis therapy up to 10x earlier than with scans
FBB Biomed in the news
• GenomeWeb – Iowa Startup FBB Biomed Pursues RNA Blood Test to Predict COVID-19 Disease Severity
• How FBB Biomed CEO Dr. Urnovitz translates basic science research into COVID-19 answers
• Interview with Dr. Urnovitz about FBB Biomed’s approach to testing and the battle against COVID-19
• FBB Biomed test design highlighted as most innovative in industry article reviewing COVID-19 tests
Background: the clinical utility of blood RNA
In this lecture, given in January 2019 at the Max Planck Institute in Martinsried, Germany, Dr. Urnovitz strongly advised expanding the work done at this site in the 1970s, but this time using next generation sequencing, bioinformatics and artificial intelligence to understand the genetic language of the blood – RNA.